VEGFB and cardiomyopathy: The integration of correlations (see Section 3.4, Figure 3A,B) allows us to conclude that CHD patients without cardiomyopathy have a coordinated angiogenic response at the organismic level with the involvement of angiogenesis activators VEGF-A, VEGF-B and SDF-1 in the peripheral blood.